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Objective: Results of routine maternal antenatal hepatitis B (HBV) screening 
have been recorded in the New South Wales (NSW) Perinatal Data Collection 
(PDC) since January 2011. We evaluated the accuracy of this reporting in 
2012, the first year that comprehensive data were available, by linking the 
PDC to HBV notifications. 
Methods: PDC records of mothers giving birth in 2012 were probabilistically 
linked to HBV notifications recorded in the NSW Notifiable Conditions 
Information Management System (NCIMS). Sensitivity and specificity of the 
PDC record of HBV status were determined using a linked HBV notification 
from the NCIMS database as the gold standard. Results were also examined 
according to health service (area health service, hospital level, public or 
private) and individual factors (maternal age, country of birth, Aboriginality, 
parity, timing of first antenatal visit). 
Results: Among 99 510 records of women giving birth in NSW in 2012, 
positive HBV status was recorded for 0.69% of the women according to the 
PDC record and 0.90% from linked NCIMS records. The overall sensitivity 
of the HBV status variable in the PDC data was 65.5% (95% confidence 
interval [CI] 62.4, 68.7) and positive predictive value was 85.3% (95% CI 82.6, 
87.9). In general, the low prevalence of HBV meant we had limited statistical 
power to assess differences between health service factors and maternal 
factors; however, sensitivity was significantly lower in PDC data for HBV in 
Australian-born non-Aboriginal women (37.0%; 95% CI 27.5, 46.7) than in 
overseas-born women (69.9%; 95% CI 66.6, 73.1; p < 0.001). 
Conclusions: PDC records of HBV status for women giving birth in 2012 
had high specificity but poor sensitivity. Sensitivity varied across area health 
services and levels of maternal services, and by various maternal factors. 
Because the results of maternal HBV screening can be used to monitor HBV 
prevalence in adults, analysis of the PDC records in subsequent years is 
necessary to track whether sensitivity improves over time.
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• Antenatal screening for hepatitis B can 
be used to monitor trends in population 
prevalence
• Estimated hepatitis B prevalence based 
on the 2012 New South Wales (NSW) 
Perinatal Data Collection was lower than 
that obtained through linkage of the 
NSW Perinatal Data Collection to NSW 
hepatitis B notifications
• Sensitivity and specificity of NSW 
hepatitis B records in the NSW Perinatal 
Data Collection vary across area health 
services, and according to various 
maternal factors 
• A similar comparison using subsequent 
years of data is necessary to track trends 
in sensitivity and specificity over time
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Introduction
Chronic hepatitis B (HBV) infection contributes to a 
significant burden of disease worldwide through its causal 
role in liver cirrhosis, liver failure and cancer. The majority 
of chronic infections are acquired through maternal 
transmission1, but this risk can be virtually eliminated with 
administration of HBV immunoglobulin and HBV vaccine 
within 48 hours of birth.2 Therefore, antenatal screening 
for chronic HBV is an important public health measure. 
Routine antenatal screening for HBV in pregnant women 
using HBV surface antigen (HBsAg) has been in place 
since 19873 in New South Wales (NSW), Australia. The 
NSW Health policy directive, effective from 1 January 
2011, on Perinatal Data Collection (PDC) reporting 
requires a birthing mother’s HBsAg status to be submitted 
as part of the pregnancy details.4 According to the NSW 
HBV Strategy, 99% of pregnant women were screened 
for HBV as part of routine antenatal care.5 As previously 
shown, information on HBsAg collected as part of 
antenatal screening can be used to assess and monitor 
HBV prevalence in the population and the impact of 
vaccination programs6,7, and therefore it is important to 
assess how accurate these data are in the PDC records.  
By linking maternal records from the PDC to HBV 
notifications from the NSW Notifiable Conditions 
Information Management System (NCIMS), we can 




The NSW PDC is a statutory record of all births in NSW 
of at least 400 grams birthweight or at least 20 weeks 
gestation, along with information on maternal health, 
including HBsAg status, demographics, pregnancy 
details and outcomes. Data are entered by the attending 
midwife or doctor either at the time of booking for delivery 
or around the time of birth for unbooked deliveries. 
The NSW NCIMS is a statutory population-based 
surveillance system with records of all notifiable 
conditions under the Public Health Act 2010.8 All 
laboratory-detected HBV infections are notifiable to the 
NCIMS. The records include personal identifying details, 
the classification of the report into either newly acquired 
HBV or HBV of unspecified duration based on standard 
definitions9, date of notification and estimated onset date. 
The NCIMS database available for this study included all 
notifications from 1 January 1994.
Linkage
We used probabilistic matching of personal identifying 
details to link records from the PDC and the NCIMS. 
The linkage was conducted by the NSW Centre for 
Health Record Linkage (CHeReL), independent of the 
study investigators, and linked, de-identified data were 
provided to the investigators for analysis. Full details of 
the linkage process can be found at www.cherel.org.au/
how-record-linkage-works. CHeReL’s reported linkage 
false positive and false negative rate is <0.5%. 
Analysis
Although collection of the HBsAg status of birthing 
women started in the PDC from 1 January 2011, it was 
known to be incomplete for that year. Thus, this study 
was limited to PDC records between 1 January 2012 and 
31 December 2012, the second year of the collection. 
A woman was defined as having an HBV infection based 
on NCIMS records if she had at least one linked record 
of an HBV notification from the NCIMS database with 
a notification date before the birthing date on the PDC 
record. Women with no linked HBV notifications were 
assumed not to have HBV infection. 
We compared the proportion of women with a positive 
HBV record from each data source using a chi-square 
test. The NCIMS notifications linked to the PDC were 
taken as the gold standard for HBV infection, and the 
accuracy of the PDC data entry for HBsAg status was 
compared to the gold standard. We calculated sensitivity, 
specificity, positive predictive value (PPV) and negative 
predictive value (NPV). The sensitivity and specificity 
for the PDC records were also estimated according 
to area health service (AHS), the hospital maternity 
service level (levels 1–4: local, district, metropolitan and 
regional referral metropolitan services for moderate-
risk pregnancies; level 5: regional referral metropolitan 
services for high-risk pregnancies; level 6: tertiary 
specialist obstetric services with neonatal intensive care 
and private hospitals), public or private hospital, maternal 
age, maternal country of birth, maternal Aboriginal and 
Torres Strait Islander status (hereafter referred to as 
Aboriginal), maternal parity (0, 1, ≥2), and timing of 
first antenatal assessment (before or after 20 weeks). 
For Aboriginal status, we improved the reporting in the 
PDC using linkage, as done previously.10 Records with 
no country of birth recorded were included in the non-
Australian-born category. 
The study was approved by the NSW Population and 
Health Services Research Ethics Committee (reference 
number 2009/11/193) and the Aboriginal Health & 
Medical Research Council Human Research Ethics 
Committee (r841/12).  
Results 
Between January and December 2012, there were 99 510 
records of mothers giving birth in the PDC. Table 1 
shows that the proportion of women with a record of 
a positive HBsAg test according to their PDC record 
(685/99 510, or 0.69%) was significantly lower than the 
proportion of women linking to a HBV notification in the 
NCIMS (891/99 510, or 0.90%; p < 0.001). Using the 
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linked NCIMS notifications as the gold standard for HBV 
infections, the overall sensitivity of the PDC data was 
65.5% (95% confidence interval [CI] 62.4, 68.7) and 
specificity was 99.9% (95% CI 99.9, 99.9). The PPV of the 
PDC data was 85.3% (95% CI 82.6, 87.9) and NPV was 
99.7% (95% CI 99.7, 99.7) (Table 2).
Comparisons between the PDC data and linked 
NCIMS notifications by AHS and by other hospital, 
sociodemographic and birth characteristics are shown in 
Tables 2 and 3. There were variations between AHSs in 
both the estimated HBV prevalence and the measures of 
agreement between records (see Table 2). For example, 
Northern Sydney and Central Coast AHS had the highest 
sensitivity of 81.0% (95% CI 73.4, 88.5) with moderate 
HBV prevalence (0.66%; 95% CI 0.53, 0.78), while 
Greater Western AHS had both the lowest sensitivity of 
33.3% (95% CI 2.5, 64.1) and the lowest HBV prevalence 
(0.23%; 95% CI 0.08, 0.38). The estimate of HBV 
prevalence using linked NCIMS records was consistently 
higher than that from the PDC in all AHSs. The biggest 
absolute difference in prevalence was in the Sydney West 
AHS (0.42%). Specificity and NPV were high in all AHSs. 
Of the other characteristics examined (see Table 3), 
there was no significant difference in estimated sensitivity 
between hospital maternity service level (levels 1–4 
versus levels 5–6, p = 0.3), private and public hospitals 
(p = 0.4), maternal age (<29 versus ≥29 years, p = 0.1) 
and parity (0 versus ≥1, p = 0.05). However, there were 
differences in sensitivity when comparing records of 
women who presented on time for antenatal care (at 
or before 20 weeks; sensitivity 64.4%; 95% CI 60.9, 
67.9) with those who presented late for antenatal care 
(sensitivity 74.0%; 95% CI 67.1, 81.0; p = 0.03). Sensitivity 
Table 1. Comparison of positive HBsAg status 
recorded in the NSW Perinatal Data Collection in 2012 
with linked hepatitis B notifications from the NCIMS
NSW Perinatal Data 
Collection record
Linked notification (NCIMS)
HBV positive HBV negative Total
HBV positive 584 101 685
HBV negative 307 98 518 98 825
Total 891a 98 619 99 510
HBsAg = hepatitis B surface antigen; HBV = hepatitis B; 
NCIMS = Notifiable Conditions Information Management System; 
NSW = New South Wales
a 17 of the 891 linked NCIMS hepatitis B notifications were for newly 
acquired hepatitis B
Table 2. Sensitivity, specificity, PPV and NPV of hepatitis B recorded in the PDC, using linked hepatitis B 
notifications as the gold standard, by area health service, 2012 
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CI = confidence interval; HBV = hepatitis B; NCIMS = Notifiable Conditions Information Management System; NPV = negative predictive value; 
PDC = NSW Perinatal Data Collection; PPV = positive predictive value
a The total includes an additional 123 records that did not have valid area health service information 
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also differed by country of birth and was highest in 
overseas-born women (69.9%; 95% CI 66.6, 73.1), 
followed by Aboriginal women (48.4%; 95% CI 30.8, 
66.0), then Australian-born non-Aboriginal women (37.0%; 
95% CI 27.5, 46.7), with a highly significant difference in 
reporting between overseas-born women and Australian-
born non-Aboriginal women (p < 0.0001).  
Table 3. Sensitivity, specificity, PPV and NPV of hepatitis B recorded in the PDC, using linked hepatitis B 
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CI = confidence interval; NCIMS = Notifiable Conditions Information Management System; NPV = negative predictive value; PDC = New South 
Wales Perinatal Data Collection; PPV = positive predictive value
a Excludes 22 records with no information on hospital maternity service level 
b Excludes 36 records with no information on parity 
c Excludes 15 records with no information on maternal date of birth/maternal age
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Discussion 
This study is the first analysis of the accuracy of HBsAg 
status reporting from the NSW PDC since the start of 
routine reporting in January 2011. The level of agreement 
of HBsAg status that we found appeared to be lower than 
that from previous validation studies on other variables 
included in PDC records. A 1998 validation study showed 
high levels of accuracy and reliability compared with 
medical records for dichotomised perinatal variables 
such as preterm birth, low and high birthweight, Apgar 
scores, perineal trauma, regional analgesia and stillbirth 
(Kappa 0.95–1.00, sensitivities 94.7–100.0%).11 The lower 
estimate of HBV prevalence from the PDC compared with 
prevalence using linked NCIMS records is consistent 
with previous analyses of PDC data for rarer events. 
For example, a study of births from 2001 to 2011 in 
NSW showed that PDC records reported lower rates 
of severe perineal injuries than linked records from the 
NSW Admitted Patient Data Collection. However, the 
discrepancy improved with time, with lower agreement 
before 2006 (Kappa 0.78; 95% CI 0.78, 0.79) than after 
2006 (Kappa 0.89; 95% CI 0.89, 0.89).12 The level of 
agreement was similar for private and public hospitals, 
in contrast to a study of PDC versus hospital records of 
postpartum haemorrhage requiring transfusion, which 
found poorer agreement for private hospitals.13 
Because the collection of HBsAg status in the PDC 
was only in its second year, and 2012 was the first 
year we were able to conduct such analyses, we were 
unable to assess the trends in accuracy over time. 
However, we hypothesise that, as the data collection 
practice becomes more ingrained in the health system, 
sensitivity will improve, as it did for the perineal trauma12 
and postpartum haemorrhage data13, and to the level of 
accuracy and reliability of other dichotomised variables 
suggested by previous validation studies.11 If reporting 
of maternal HBV status in the PDC data becomes more 
reliable, it could be used to determine HBV prevalence 
across different AHSs and population groups, as well as 
to monitor prevalence changes over time, as has been 
done in previous studies using linked data.6,7
Variations in accuracy across AHSs, and important 
sociodemographic factors such as country of birth 
also require further analysis over time to determine if 
there are consistent factors that affect the accuracy of 
reporting. The better sensitivity in women presenting late 
to antenatal clinics and those born overseas suggest 
greater vigilance in HBV-status recording in populations 
considered to be at higher risk of HBV. 
In this study, we were limited to using linked NCIMS 
records as the gold standard because we did not have 
access to medical records and patient pathology records, 
which would have provided us with the most accurate 
information on the patient’s HBsAg status and thus be 
the ultimate gold standard. It is possible that some linked 
NCIMS notifications of HBV of unspecified duration could 
have been acute HBV infections that cleared by the time 
the woman became pregnant. Thus, the woman may 
have tested negative during her pregnancy and this 
would be recorded as such on the PDC. It is also possible 
that the woman tested positive after her characteristics 
were entered into the PDC and that her record was 
not updated. The study is also limited by false positive 
and false negative linkages that may have affected the 
accuracy of the linked NCIMS records. 
Conclusion 
Accurate perinatal recording of HBV infection status 
based on routine screening provides a simple and cost-
effective means of monitoring population patterns and 
trends in HBV prevalence in birthing women, and could 
be used in Australia6,7 and internationally.14 This study 
showed that HBV prevalence as reported on NSW PDC 
records for birthing women in 2012, its second year of 
reporting, was lower than the estimate obtained by linking 
PDC records to NCIMS HBV notifications. There was also 
some variability in measures of agreement according 
to AHS, timing of first antenatal assessment, country 
of birth and Aboriginal status. Further assessment of 
the accuracy of PDC reporting over time will determine 
whether it can be used for monitoring prevalence in 
NSW, and whether similar reporting systems should be 
implemented elsewhere in Australia.
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